Logos Global Management L.P. 13F annual report

Logos Global Management L.P. is an investment fund managing more than $1.72 trillion ran by Derek Gould. There are currently 50 companies in Mr. Gould’s portfolio. The largest investments include IDEAYA Biosciences and Argenx Se, together worth $235 billion.

Limited to 30 biggest holdings

$1.72 trillion Assets Under Management (AUM)

As of 20th August 2024, Logos Global Management L.P.’s top holding is 3,400,000 shares of IDEAYA Biosciences currently worth over $119 billion and making up 6.9% of the portfolio value. Relative to the number of outstanding shares of IDEAYA Biosciences, Logos Global Management L.P. owns less than approximately 0.1% of the company. In addition, the fund holds 270,000 shares of Argenx Se worth $116 billion. The third-largest holding is Merus N.V worth $101 billion and the next is Revolution Medicines Inc worth $93.1 billion, with 2,400,000 shares owned.

Currently, Logos Global Management L.P.'s portfolio is worth at least $1.72 trillion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Logos Global Management L.P.

The Logos Global Management L.P. office and employees reside in San Francisco, California. According to the last 13-F report filed with the SEC, Derek Gould serves as the GC/CCO at Logos Global Management L.P..

Recent trades

In the most recent 13F filing, Logos Global Management L.P. revealed that it had opened a new position in Argenx Se and bought 270,000 shares worth $116 billion.

The investment fund also strengthened its position in IDEAYA Biosciences by buying 1,900,000 additional shares. This makes their stake in IDEAYA Biosciences total 3,400,000 shares worth $119 billion. IDEAYA Biosciences dropped approximately 0.1% in the past year.

On the other hand, there are companies that Logos Global Management L.P. is getting rid of from its portfolio. Logos Global Management L.P. closed its position in Immunocore Hldgs Plc on 27th August 2024. It sold the previously owned 900,000 shares for $58.5 billion. Derek Gould also disclosed a decreased stake in Sarepta Therapeutics Inc by 0.3%. This leaves the value of the investment at $47.4 billion and 300,000 shares.

One of the largest hedge funds

The two most similar investment funds to Logos Global Management L.P. are Sageview Advisory and Quintet Private Bank (europe) S.A.. They manage $1.72 trillion and $1.72 trillion respectively.


Derek Gould investment strategy

Logos Global Management L.P.’s portfolio is diversified across 2 sectors. Currently, their heaviest sector is Health Care — making up 54.5% of the total portfolio value. The fund focuses on investments in the United States as 44.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are small-cap stocks. Stocks with a size of more than $100 million in market cap make up 12% of the total holdings value. On the other hand, large-cap stocks make up only 2.0% of the portfolio. The average market cap of the portfolio companies is close to $1.56 billion.

The complete list of Logos Global Management L.P. trades based on 13F SEC filings

These positions were updated on August 27th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
IDEAYA Biosciences, Inc.
126.67%
3,400,000
$119,374,000,000 6.92%
Argenx Se
Opened
270,000
$116,110,800,000 6.73%
Merus N.V
Opened
1,700,000
$100,589,000,000 5.83%
Revolution Medicines Inc
Opened
2,400,000
$93,144,000,000 5.40%
Structure Therapeutics Inc
205.53%
2,200,000
$86,394,000,000 5.01%
Disc Medicine Inc
Opened
1,850,000
$83,379,500,000 4.84%
Ocular Therapeutix Inc
77.24%
10,300,000
$70,452,000,000 4.09%
Olema Pharmaceuticals, Inc.
46.39%
6,417,750
$69,440,056,000 4.03%
Vera Therapeutics Inc
230.43%
1,900,000
$68,742,000,000 3.99%
Moonlake Immunotherapeutics
Opened
1,500,000
$65,955,000,000 3.83%
Janux Therapeutics Inc
900.00%
1,500,000
$62,835,000,000 3.64%
Immunocore Hldgs Plc
Closed
900,000
$58,500,000,000
Xencor Inc
361.54%
3,000,000
$56,790,000,000 3.29%
Silence Therapeutics plc
100.00%
2,952,122
$56,090,318,000 3.25%
Sarepta Therapeutics Inc
25.00%
300,000
$47,400,000,000 2.75%
Akero Therapeutics Inc
100.00%
1,600,000
$37,536,000,000 2.18%
Design Therapeutics Inc
100.00%
10,065,002
$33,717,756,000 1.96%
Annexon Inc
116.39%
6,600,000
$32,340,000,000 1.88%
Apellis Pharmaceuticals Inc
No change
800,000
$30,688,000,000 1.78%
Immunovant Inc
35.21%
1,150,000
$30,360,000,000 1.76%
Geron Corp.
Closed
9,000,000
$29,700,000,000
Nuvalent Inc
Opened
390,000
$29,585,400,000 1.72%
Xenon Pharmaceuticals Inc
Opened
750,000
$29,242,500,000 1.70%
Ionis Pharmaceuticals Inc
Opened
600,000
$28,596,000,000 1.66%
Stoke Therapeutics, Inc.
Opened
2,100,000
$28,371,000,000 1.65%
Erasca Inc
Opened
11,800,000
$27,848,000,000 1.62%
Enliven Therapeutics Inc
24.41%
1,190,000
$27,810,300,000 1.61%
Celldex Therapeutics Inc.
Closed
650,000
$27,280,500,000
Spyre Therapeutics Inc
360.00%
1,150,000
$27,036,500,000 1.57%
Engene Holdings Inc
200.00%
2,400,000
$22,632,000,000 1.31%
Cybin Inc
100.00%
80,000,000
$21,680,000,000 1.26%
Skye Bioscience Inc
Opened
2,603,036
$20,850,318,000 1.21%
Elevation Oncology Inc
670.00%
7,700,000
$20,790,000,000 1.21%
Dyne Therapeutics, Inc.
69.36%
530,000
$18,703,700,000 1.08%
Biohaven Ltd
Opened
500,000
$17,355,000,000 1.01%
Relay Therapeutics, Inc.
Opened
2,600,000
$16,952,000,000 0.98%
Trevi Therapeutics, Inc.
154.55%
5,600,000
$16,688,000,000 0.97%
Rocket Pharmaceuticals Inc
46.15%
700,000
$15,071,000,000 0.87%
COMPASS Pathways plc
798.54%
2,318,060
$14,001,082,000 0.81%
Cg Oncology Inc
Closed
300,000
$13,170,000,000
Kyverna Therapeutics Inc
Closed
500,000
$12,420,000,000
Viridian Therapeutics Inc
Closed
700,000
$12,257,000,000
Cullinan Oncology, LLC
Closed
700,000
$11,928,000,000
Immatics N.v
Closed
1,000,000
$10,510,000,000
Lineage Cell Therapeutics In
50.40%
9,400,000
$9,374,620,000 0.54%
Atyr Pharma Inc
93.55%
6,000,000
$9,360,000,000 0.54%
Praxis Precision Medicines I
Closed
150,000
$9,153,000,000
Astria Therapeutics Inc
19.68%
1,000,000
$9,100,000,000 0.53%
Syndax Pharmaceuticals Inc
Closed
350,000
$8,330,000,000
Nextcure Inc
159.74%
5,000,000
$7,950,000,000 0.46%
Cytokinetics Inc
Closed
100,000
$7,011,000,000
Avalo Therapeutics Inc
Opened
539,079
$6,722,315,000 0.39%
Kura Oncology Inc
Closed
300,000
$6,399,000,000
Neumora Therapeutics Inc.
56.93%
600,000
$5,898,000,000 0.34%
Allakos Inc
100.00%
5,800,000
$5,800,000,000 0.34%
Adverum Biotechnologies Inc
44.44%
833,332
$5,716,658,000 0.33%
Applied Therapeutics, Inc.
11.11%
1,200,000
$5,323,800,000 0.31%
Cartesian Therapeutics Inc
Opened
180,000
$4,861,800,000 0.28%
Rapport Therapeutics Inc
Opened
208,910
$4,373,322,000 0.25%
Unicycive Therapeutics Inc
100.00%
6,939,854
$3,477,560,000 0.20%
Tourmaline Bio Inc
Closed
99,208
$2,271,863,000
Io Biotech Inc
100.00%
987,654
$1,155,556,000 0.07%
Immunic, Inc.
Closed
421,184
$555,963,000
Boundless Bio Inc
41.10%
117,806
$433,114,000 0.03%
Leap Therapeutics Inc
Closed
39,500
$105,070,000
No transactions found
Showing first 500 out of 65 holdings